While semaglutide can be a powerful tool for weight management and managing type 2 diabetes in women, it's important to be aware of potential side effects. Common side effects may include nausea, vomiting, diarrhea, and constipation. These effects are usually mild and tend to decrease over time a
FDA Warning: Hidden Dangers of Smuggled Tirzepatide in Peptide Markets
The FDA has issued a warning about the risks of smuggled tirzepatide as the peptide therapeutics market grows rapidly. The market is expected to jump from $38 billion in 2023 to $106 billion by 2033, with an impressive 10.8% compound annual growth rate. Legitimate peptide medications have copyright